efalizumab monoclonal antibody drug. targets cd11a but was withdrawn from the market due to safety issues. generic name and

antibody autoimmune biological biosimilar biotech biotechnology cd11a disease drug efalizumab immunoglobulin immunology infusion injection inn mab monoclonal nomenclature peptide protein psoriasis recombinant withdrawn